News

Perioperative nivolumab significantly improved survival and pathological response in stage III non-small-cell lung cancer, challenging the traditionally poor prognosis associated with N2 nodal disease.

Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with type 2 diabetes.

Across these trials, anti-inflammatory treatment significantly reduced anhedonia, defined as reduced capacity to experience pleasure, with a moderate effect size.

A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide regional variation and delays before specialist referral limiting progress

New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier.

A target trial emulation study finds no relapse reduction with cyclophosphamide added to glucocorticoids in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors.

Find out how robot-assisted therapy for autism matches standard treatment outcomes while improving engagement and expanding access in clinical and community settings.

A recent study links chemotherapy to impaired ovarian function and fertility through oxidative damage to ovarian follicles.